Machelle Sanders Net Worth

The estimated Net Worth of Machelle Sanders is at least $67.3 Tisíc dollars as of 17 June 2024. Ms. Sanders owns over 4,689 units of Novan Inc stock worth over $2,497 and over the last 7 years she sold NOVN stock worth over $64,791. In addition, she makes $0 as Independent Director at Novan Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Sanders NOVN stock SEC Form 4 insiders trading

Machelle has made over 5 trades of the Novan Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently she sold 4,689 units of NOVN stock worth $28,134 on 17 June 2024.

The largest trade she's ever made was exercising 36,101 units of Novan Inc stock on 6 June 2023 worth over $3,249. On average, Machelle trades about 3,519 units every 87 days since 2017. As of 17 June 2024 she still owns at least 27,742 units of Novan Inc stock.

You can see the complete history of Ms. Sanders stock trades at the bottom of the page.

Machelle Sanders biography

Machelle Sanders serves as Independent Director of the Company. Ms. Sanders is currently serving as the Secretary of the N.C. Department of Administration, appointed by Governor Roy Cooper. In the private sector, Ms. Sanders was most recently responsible for the pharmaceutical operations and technology operational strategy at Biogen, Inc., a multinational biotechnology company, as vice president of quality assurance and vice president of manufacturing and general manager from 2009 to 2015. Ms. Sanders has also held leadership positions in manufacturing, global quality assurance and quality control at Biogen, Inc., Purdue Pharmaceuticals, a pharmaceutical company, and Diosynth-Akzu Nobel, a company that develops and offers manufacturing processes for active ingredients for pharmaceutical companies.

How old is Machelle Sanders?

Machelle Sanders is 57, she's been the Independent Director of Novan Inc since 2017. There are 5 older and 8 younger executives at Novan Inc. The oldest executive at Novan Inc is Robert Ingram, 77, who is the Independent Director.

What's Machelle Sanders's mailing address?

Machelle's mailing address filed with the SEC is 4505 EMPEROR BLVD., SUITE 200, DURHAM, NC, 27703.

Insiders trading at Novan Inc

Over the last 8 years, insiders at Novan Inc have traded over $72,487 worth of Novan Inc stock and bought 1,476,993 units worth $9,839,419 . The most active insiders traders include John W Palmour, Robert J Keegan a Life Sciences Holdings Ltd .... On average, Novan Inc executives and independent directors trade stock every 70 days with the average trade being worth of $4,566. The most recent stock trade was executed by Machelle Sanders on 27 June 2023, trading 11,553 units of NOVN stock currently worth $4,737.

What does Novan Inc do?

novan, inc. is a clinical-stage biotechnology company focused on leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases. we believe that our ability to conveniently deploy nitric oxide in a solid form, on demand and in localized formulations allows us the potential to significantly improve patient outcomes in a variety of diseases.

Complete history of Ms. Sanders stock trades at Biocryst Pharmaceuticals, Novan Inc a Radius Recycling

Novan Inc executives and stock owners

Novan Inc executives and other stock owners filed with the SEC include:

• Paula Brown Stafford M.P.H.,
  Pres, CEO & Chairwoman
• Paula Brown Stafford,
  Pres, CEO & Chairwoman
• Paula Stafford,
  Chairman of the Board, President, Chief Executive Officer
• John M. Gay CPA,
  CFO & Corp. Sec.
• John M. Gay,
  CFO & Corp. Sec.
• John Gay,
  Chief Financial Officer, Vice President - Finance, Corporate Controller, Corporate Secretary
• Robert Ingram,
  Independent Director
• Jenene Thomas,
  Investors Relation
• Machelle Sanders,
  Independent Director
• John Palmour,
  Independent Director
• Robert Keegan,
  Independent Director
• James Bierman,
  Director
• W. Geer,
  Lead Independent Director
• Stanley Hollenbach BS, J.D.,
  Sr. VP of R&D
• John A. Donofrio Jr.,
  Exec. VP, COO & Pres of EPI Health
• Dr. Tomoko Maeda-Chubachi M.B.A., M.D., Ph.D.,
  Chief Medical Officer
• Brian M. Johnson,
  Chief Commercial Officer
• Elizabeth Messersmith,
  Sr. VP & Chief Devel. Officer
• Stanley Hollenbach BS,J.D.,
  Sr. VP of R&D
• Cole Ikkala,
  Director of Investor Relations, Communications & Bus. Devel.
• Dr. Carri Geer,
  Sr. VP & CTO
• Andrew J. Novak,
  VP of Accounting & Bus. Operations and Chief Accounting Officer
• Brian M. Johnson,
  Chief Commercial Officer
• Life Sciences Holdings Ltd ...,
  
• Sean Murphy,
  Director
• Nathan Stasko,
  President & CSO, Director
• G. Kelly Martin,
  Chief Executive Officer
• William L Hodges,
  Interim Chief Financial Office
• M. Joyce Rico,
  Chief Medical Officer
• F Nealt.D.H. One, Llct.D.H....,
  
• A. Donofrio John,
  EVP, Chief Operating Officer
• Eugene Sun,
  Director
• Jeff N Hunter,
  EVP & Chief Business Officer
• Steven D Skolsky,
  Director